SEMMAX FINANCIAL ADVISORS INC. – Alnylam Pharmaceuticals, Inc. Transaction History
SEMMAX FINANCIAL ADVISORS INC. portfolio value:
$3,000
portfolio value
SEMMAX FINANCIAL ADVISORS INC. quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -98.29% | -807 shares | -187K | $200.16 | 14 |
| Q2 2022 | share | Decrease | -10.86% | -100 shares | 40K | $145.85 | 821 |
| Q1 2022 | share | Decrease | -7.25% | -72 shares | -18K | $163.29 | 921 |
| Q4 2021 | share | Decrease | -15.99% | -189 shares | -55K | $171.03 | 993 |
| Q3 2021 | share | Decrease | -10.45% | -138 shares | -1K | $188.81 | 1.18K |
| Q2 2021 | share | Increase | +1.46% | 19 shares | 40K | $169.52 | 1.32K |
| Q1 2021 | share | Increase | 0.00% | 1.30K shares | 184K | $141.19 | 1.30K |